RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
More Medicare Beneficiaries Are Initiated on Direct Oral Anticoagulants According to a Recent Avalere Analysis
New Avalere analysis evaluates the trends in baseline patient characteristics among Medicare fee-for-service beneficiaries with stand-alone Part D coverage who initiated a direct oral anticoagulant during the period 2013–2017.
Get the Most Out of In-Home Assessments to Retain Members and Improve Health Outcomes
As health plans evaluate more efficient ways to engage and retain members, they should focus on existing high-touch points to improve healthcare access and the overall experience. Augmenting these efforts can generate more evidence-based patient management thus improving overall health outcomes.
Avalere Releases Recommendations to Drive More Patient Orientation in Value Assessment Methodology
Avalere published a white paper outlining global recommendations to increase the patient centricity of value assessment framework methodology and application.
Comparing the Effectiveness of New Versus Established Multiple Sclerosis Therapies in the Managed Medicaid Population
Avalere experts recently presented their research, “Comparison of Healthcare Utilization Among Managed Medicaid Individuals Diagnosed with Multiple Sclerosis Treated with Emergent vs. Established Disease-Modifying Therapy in the US.”
Avalere Research and Expertise to be Featured at AMCP and ISPOR Conferences
In the coming months, Avalere experts will be presenting new data and research at major conferences, featuring insights derived from Inovalon’s Medical Outcomes Research for Effectiveness and Economics Registry (MORE2 Registry®).
Opportunities for Real-World Data Will Grow as Big Tech Embraces Healthcare Partnerships
Partnerships between traditional healthcare players and big technology companies seek to improve care delivery and patient outcomes in innovative ways.
Avalere Partners with Leading Providers and Advocacy Groups to Chart Course for SDM in Cancer Care
Despite recognition that providers should implement shared decision making (SDM) as standard practice, integration of SDM into regular care delivery remains elusive.
Mental Illness Research Wins Award
Findings from a new Avalere study, titled “Prevalence and Likelihood of Hospital Admission and Readmission in Patients with Serious Mental Illness,” were presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Asia Pacific conference on Sunday, September 9, 2018.
Developing a Shared Decision-Making Tool in Collaboration with Patients and Clinicians
Avalere used a human-centered design approach structured around patient preferences to help guide advanced breast cancer patients.
HTA Oncology Recommendations Have Grown More Restrictive Over Time
Of the 329 oncology HTAs analyzed from the period 2013–2017, 29% resulted in positive recommendations without restrictions.
Avalere Releases Patient-Perspective Value Framework Scoring Methodology Report
Today, Avalere published a technical appendix to the PPVF Version 1.0 methodology report, outlining a quantitative method for incorporating patient preferences into value assessments and healthcare decision making.
Interview: E2 – Real-World Evidence: Is It a Game Changer for the FDA?
Episode 2 of our discussion covers why the FDA is so interested in real-world evidence and how they are approaching it.
Avalere Expands Actuarial and Data Analytics Expertise with Hire of Kenny Kan
Kenny Kan has joined the Avalere team leading the firm's actuarial analytics. Prior to joining Avalere, Kan served as the Chief Actuary at Humana and CareFirst.
Gillian Woollett’s Research Published in BioDrugs
Gillian Wollett, Senior Vice President of Avalere’s FDA & Regulatory Policy team, recently published “A ‘Global Reference’ Comparator for Biosimilar Development” in BioDrugs.
Issue Brief: The Promise of Shared Decision-Making in Improving Value in the US Healthcare System
Evidence suggests that shared decision-making can play a role in advancing a value-based care delivery system.
Christie Teigland Contributes to NQF’s Disparities Report
Avalere’s Teigland was selected by the National Quality Forum to participate in the Disparities Standing Committee.
Interview: Key Differences Within the Patient-Perspective Value Framework
Our experts discuss the key differences making the the Patient-Perspective Value Framework 1.0 (PPVF) unique compared to value frameworks currently in the market.
Avalere to Participate in National Academies of Medicine Panel
On Tuesday, June 13, Christie Teigland, PhD, will participate in a panel discussion entitled “Measuring and Reporting Social Risk Factors” as part of a dissemination meeting on the report series “Accounting for Social Risk Factors in Medicare Payment,” sponsored by the National Academies of Medicine.
Webinar: Outcomes-Based Contracting: Master the Challenges
Avalere experts examine the challenges and successful approaches to outcomes-based contracts.
Health Plans Are Actively Exploring Outcomes-Based Contracts
Avalere experts say use of outcomes-based contracts could further goals to improve patient outcomes and manage drug costs